RecallRadar

FDA Device recall Z-1909-2016

CytoScan¿ Dx Assay

On 2016-06-08 the FDA classified a Class III recall of CytoScan¿ Dx Assay by Affymetrix, citing during a recent Ohio site inspection by the FDA it was discovered that warning statements needed to be included with the product shipment.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1909-2016
ClassificationClass III
Statusterminated
Initiated2016-04-14
Published2016-06-08
Last updated2026-09-13 11:54 UTC
CompanyAffymetrix
DistributionAR, CA, DC, MA, MI, MN, NC, NM, NY, PA, SC, TN, TX, WA, WV

Product

CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software: MOD R LA, CytoScan¿ Dx Pre-PCR (-20¿C) MOD T E W, CytoScan¿ Dx Pre-PCR (2¿-8¿C) MOD F L H, CytoScan¿ Dx Post-PCR (-20¿C) MOD S AH W PB, CytoScan¿ Dx Post-PCR (2¿-8¿C) MOD E PW, CytoScan¿ Dx Post-PCR (15¿- 30¿ C) CytoScan Dx WS A CytoScan Dx WS B CytoScan¿ Dx Array kit, 6Pk ChAS Dx Analysis Software and Browser

Reason

During a recent Ohio site inspection by the FDA it was discovered that warning statements needed to be included with the product shipment.

Identifiers

code_info
4044094 exp 6/10/17; 4044095 exp 6/10/17 ;4044148 exp 10/14/17 ;4044149 exp 10/14/17 ;4044150 exp 12/17/17; 4044151 exp…4044094 exp 6/10/17; 4044095 exp 6/10/17 ;4044148 exp 10/14/17 ;4044149 exp 10/14/17 ;4044150 exp 12/17/17; 4044151 exp 12/17/17 ; 4044160* exp 3/31/15 and 4244477* exp 12/31/15. *Expiry of initial commercial lots was 12 -18 months.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1909-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.